103 related articles for article (PubMed ID: 19124005)
1. Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells.
Lin CI; Whang EE; Abramson MA; Donner DB; Bertagnolli MM; Moore FD; Ruan DT
Biochem Biophys Res Commun; 2009 Feb; 379(2):626-31. PubMed ID: 19124005
[TBL] [Abstract][Full Text] [Related]
2. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
[TBL] [Abstract][Full Text] [Related]
4. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.
Lavra L; Ulivieri A; Rinaldo C; Dominici R; Volante M; Luciani E; Bartolazzi A; Frasca F; Soddu S; Sciacchitano S
J Pathol; 2009 May; 218(1):66-75. PubMed ID: 19199318
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathway.
Kim MJ; Kim HB; Bae JH; Lee JW; Park SJ; Kim DW; Park SI; Kang CD; Kim SH
Biochem Pharmacol; 2009 Sep; 78(6):573-82. PubMed ID: 19464267
[TBL] [Abstract][Full Text] [Related]
6. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.
Lin CI; Whang EE; Donner DB; Jiang X; Price BD; Carothers AM; Delaine T; Leffler H; Nilsson UJ; Nose V; Moore FD; Ruan DT
Mol Cancer Res; 2009 Oct; 7(10):1655-62. PubMed ID: 19825987
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
9. Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia.
Maraldi T; Bertacchini J; Benincasa M; Guida M; De Pol A; Liotta LA; Petricoin E; Cocco L; Marmiroli S
Int J Oncol; 2011 Feb; 38(2):427-35. PubMed ID: 21132263
[TBL] [Abstract][Full Text] [Related]
10. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
11. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
Lee DH; Szczepanski MJ; Lee YJ
J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
[TBL] [Abstract][Full Text] [Related]
12. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
[TBL] [Abstract][Full Text] [Related]
13. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
Gagnon V; Van Themsche C; Turner S; Leblanc V; Asselin E
Apoptosis; 2008 Feb; 13(2):259-71. PubMed ID: 18071906
[TBL] [Abstract][Full Text] [Related]
14. The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases.
Audo R; Combe B; Coulet B; Morel J; Hahne M
Cell Death Differ; 2009 Sep; 16(9):1227-37. PubMed ID: 19407827
[TBL] [Abstract][Full Text] [Related]
15. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
Shalom-Feuerstein R; Cooks T; Raz A; Kloog Y
Cancer Res; 2005 Aug; 65(16):7292-300. PubMed ID: 16103080
[TBL] [Abstract][Full Text] [Related]
17. De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.
Rath G; Schneider C; Langlois B; Sartelet H; Morjani H; Btaouri HE; Dedieu S; Martiny L
Int J Biochem Cell Biol; 2009 May; 41(5):1165-72. PubMed ID: 19027085
[TBL] [Abstract][Full Text] [Related]
18. MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells.
Siragusa M; Zerilli M; Iovino F; Francipane MG; Lombardo Y; Ricci-Vitiani L; Di Gesù G; Todaro M; De Maria R; Stassi G
Cancer Res; 2007 Jun; 67(11):5522-30. PubMed ID: 17545635
[TBL] [Abstract][Full Text] [Related]
19. On the role of galectin-3 in cancer apoptosis.
Nakahara S; Oka N; Raz A
Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
[TBL] [Abstract][Full Text] [Related]
20. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]